Lakewood-Amedex Biotherapeutics, a clinical-stage biotech company developing a novel class of fast-acting antimicrobials called Bisphosphocin®, announced that CEO Kelvin Cooper will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14-16, 2026. During the event, Cooper will meet with investors and partners to discuss the company's clinical development strategy, recent achievements, and upcoming milestones. This presentation highlights the company's efforts to combat antibiotic-resistant bacteria such as MRSA and VRE with its innovative treatments.
Apple reported its strongest June quarter ever with revenue of $109.42 billion, up 16.36% year-over-year, and earnings per share of $2.02, beating expectations for the ninth consecutive quarter. Key growth drivers include a $54 billion hardware segme...
Strategy, led by Michael Saylor, purchased 4,603 Bitcoin at an average price of $80,318 each in late August 2026, increasing its total Bitcoin holdings to 845,050 BTC. This marks the company's first Bitcoin purchase in 10 weeks after selling nearly 7...
Circle announced it will acquire Singapore-based Tazapay, a B2B cross-border payments company, to enhance adoption of its USDC stablecoin. The acquisition leverages Tazapay's extensive banking network and payout infrastructure across over 100 markets...
Dell Technologies and NVIDIA both reported strong AI-driven revenue growth in Q2 FY27, with Dell posting $46.97 billion revenue and NVIDIA $96.22 billion. While NVIDIA dominates as the AI compute platform owner with high margins, Dell is gaining grou...
Chevron benefits directly from the Iran conflict and rising prices for oil and related commodities, with global reserves at critical lows. Its Project Kilby will monetize Permian Basin natural gas by powering a large Microsoft AI data center under a ...
